Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. (Q44675420)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. |
scientific article |
Statements
1 reference
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. (English)
1 reference
Deanne M R Lathers
1 reference
Joseph I Clark
1 reference
Nicholas J Achille
1 reference
M Rita I Young
1 reference
26 November 2003
1 reference
1 reference
Identifiers
1 reference